Skip to main content

Table 3 Demographics of study subjects (N = 339)

From: A novel method for early detection of colorectal cancer based on detection of methylation of two fragments of syndecan-2 (SDC2) in stool DNA

Characteristics Overall CRC
n (%)
Advanced adenomas
n (%)
Non‐advanced adenoma
n (%)
Colitis
n (%)
Normal control
n (%)
P value
Number 339 102 50 39 18 130  
Gender        0.054
Male 173 (51.03%) 50 (49.02%) 35 (70.00%) 19 (48.72%) 10 (55.56%) 59 (45.38%)  
Female 166 (48.97%) 52 (50.98%) 15 (30.00%) 20 (51.28%) 8 (44.44%) 71 (54.62%)  
Median age (years, range)         < 0.001
 < 35 40 (11.81%) 3 (2.94%) 2 (4.00%) 4 (10.26%) 5 (27.78%) 26 (20.00%)  
35–45 47 (13.86%) 10 (9.80%) 1 (2.00%) 1 (2.56%) 4 (22.22%) 31 (23.85%)  
46–55 65 (19.17%) 13 (12.75%) 12 (24.00%) 13 (33.33%) 4 (22.22%) 23 (17.69%)  
 > 55 187 (55.16%) 76 (74.51%) 35 (70.00%) 21 (53.85%) 5 (27.78%) 50 (38.46%)  
Clinical stage        /
0 / 4 (3.92%) / / / /  
I / 11 (10.78%) / / / /  
II / 28 (27.45%) / / / /  
III / 34 (33.34%) / / / /  
IV / 2 (1.96%) / / / /  
Not determined / 23 (22.55%) / / / /